Insiders · ALXN

ALXN insider transactions

Alexion Pharmaceuticals, Inc. (ALXN) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for ALXN

• 1781d
  SEC Form 4: COUGHLIN CHRISTOPHER J returned 42,347 units of Common Stock to the company, closing all direct ownership in the company

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1781d
  SEC Form 4: FRIEDMAN PAUL A returned 12,840 units of Common Stock to the company, closing all direct ownership in the company

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1781d
  SEC Form 4: SARIN ARADHANA returned 120,253 units of Common Stock to the company, closing all direct ownership in the company

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1781d
  SEC Form 4: Reinsdorf Judith A returned 14,150 units of Common Stock to the company, closing all direct ownership in the company

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1781d
  SEC Form 4: Dunsire Deborah returned 14,629 units of Common Stock to the company, closing all direct ownership in the company

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1781d
  SEC Form 4: Chiniara Ellen returned 116,850 units of Common Stock to the company, closing all direct ownership in the company

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1781d
  SEC Form 4: Goff Brian returned 150,832 units of Common Stock to the company, closing all direct ownership in the company

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1781d
  SEC Form 4: Brennan David R returned 20,873 units of Common Stock to the company, closing all direct ownership in the company

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1781d
  SEC Form 4: Mollen John T returned 15,336 units of Common Stock to the company, closing all direct ownership in the company

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1781d
  SEC Form 4: Carino Tanisha returned 59,226 units of Common Stock to the company, closing all direct ownership in the company

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1781d
  SEC Form 4: Nader Francois returned 13,921 units of Common Stock to the company, closing all direct ownership in the company

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1781d
  SEC Form 4: Franchini Indrani Lall returned 116,075 units of Common Stock to the company, closing all direct ownership in the company

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1781d
  SEC Form 4 filed by Alexion Pharmaceuticals, Inc.

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1781d
  SEC Form 4: ORLOFF JOHN J returned 146,511 units of Common Stock to the company, closing all direct ownership in the company

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1781d
  SEC Form 4: HANTSON LUDWIG returned 580,809 units of Common Stock to the company, decreasing direct ownership by 98% to 9,098 units

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1781d
  SEC Form 4: Rummelt Andreas returned 28,109 units of Common Stock to the company, closing all direct ownership in the company

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1788d
  SEC Form 4: HANTSON LUDWIG was granted 240,741 units of Common Stock, increasing direct ownership by 69% to 589,907 units

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1788d
  SEC Form 4: SARIN ARADHANA was granted 56,313 units of Common Stock, increasing direct ownership by 88% to 120,253 units

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1788d
  SEC Form 4: Franchini Indrani Lall was granted 52,625 units of Common Stock, increasing direct ownership by 83% to 116,075 units

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1788d
  SEC Form 4: ORLOFF JOHN J was granted 60,144 units of Common Stock, increasing direct ownership by 70% to 146,511 units

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1788d
  SEC Form 4: Bazarko Daniel was granted 21,708 units of Common Stock, increasing direct ownership by 56% to 60,207 units

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1788d
  SEC Form 4: Chiniara Ellen was granted 54,469 units of Common Stock, increasing direct ownership by 87% to 116,850 units

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1788d
  SEC Form 4: Carino Tanisha was granted 25,813 units of Common Stock, increasing direct ownership by 77% to 59,226 units

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1788d
  SEC Form 4: Goff Brian was granted 60,144 units of Common Stock, increasing direct ownership by 66% to 150,832 units

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1825d
  SEC Form 4: ORLOFF JOHN J covered exercise/tax liability with 1,957 units of Common Stock, decreasing direct ownership by 2% to 86,367 units (withholding tax)

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1825d
  SEC Form 4: Goff Brian covered exercise/tax liability with 1,086 units of Common Stock, decreasing direct ownership by 1% to 90,688 units (withholding tax)

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1825d
  SEC Form 4: Franchini Indrani Lall covered exercise/tax liability with 928 units of Common Stock, decreasing direct ownership by 1% to 63,450 units (withholding obligation)

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1841d
  SEC Form 4: FRIEDMAN PAUL A was granted 2,495 units of Common Stock, increasing direct ownership by 24% to 12,840 units

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1841d
  SEC Form 4: Rummelt Andreas was granted 2,495 units of Common Stock, increasing direct ownership by 10% to 28,109 units

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1841d
  SEC Form 4: Nader Francois was granted 2,635 units of Common Stock, increasing direct ownership by 23% to 13,921 units

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1841d
  SEC Form 4: Dunsire Deborah was granted 2,495 units of Common Stock, increasing direct ownership by 21% to 14,629 units

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1895d
  SEC Form 4: Ludwig Hantson disposed of $359,198 worth of Common Stock (2,332 units at $154.03), decreasing direct ownership by 0.66% to 349,166 units

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1924d
  SEC Form 4: Ludwig Hantson was granted 83,725 units of Common Stock, increasing ownership by 31% to 351,498 units

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1924d
  SEC Form 4: Tanisha Carino was granted 18,033 units of Common Stock and disposed of $109,564 worth of Common Stock (722 units at $151.75), increasing ownership by 108% to 33,413 units

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1924d
  SEC Form 4: Ellen Chiniara was granted 19,321 units of Common Stock, increasing ownership by 45% to 62,381 units

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1924d
  SEC Form 4: Brian Goff was granted 24,473 units of Common Stock, increasing ownership by 36% to 91,774 units

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1924d
  SEC Form 4: Lall Indrani Franchini was granted 18,033 units of Common Stock, increasing ownership by 39% to 64,378 units

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1924d
  SEC Form 4: Aradhana Sarin was granted 24,473 units of Common Stock, increasing ownership by 62% to 63,940 units

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1924d
  SEC Form 4: J John Orloff was granted 24,473 units of Common Stock, increasing ownership by 38% to 88,324 units

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)
• 1924d
  SEC Form 4: Daniel Bazarko was granted 7,616 units of Common Stock, increasing ownership by 25% to 38,499 units

  4 - ALEXION PHARMACEUTICALS, INC. (0000899866) (Issuer)